news
Scientists have developed a drug-like molecule to target amyloid-beta, a…
6 November 2020 | By Hannah Balfour (Drug Target Review)
Scientists have developed a drug-like molecule to target amyloid-beta, a disordered protein implicated in Alzheimer's disease that has been considered undruggable.